Breast cancer protein called cyclin. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy13

Breast Cell Line, Tumor Tumor Cells, Cultured MCF-7 Cells Mammary Glands, Human Axilla Nipples Lymph Nodes Neoplastic Stem Cells Cell Line Epithelial Cells Cell Nucleus Neoplastic Cells, Circulating

Organisms2

Mice, Nude Mice, SCID

Diseases38

Neoplasms Breast Neoplasms Carcinoma, Ductal, Breast Breast Diseases Neoplasm Metastasis Neoplasm Invasiveness Breast Neoplasms, Male Carcinoma, Lobular Carcinoma, Intraductal, Noninfiltrating Genetic Predisposition to Disease Carcinoma Mammary Neoplasms, Experimental Neoplasms, Hormone-Dependent Ovarian Neoplasms Lymphatic Metastasis Neoplasm Recurrence, Local Lung Neoplasms Fibrocystic Breast Disease Disease Progression Prostatic Neoplasms Cell Transformation, Neoplastic Bone Neoplasms Colonic Neoplasms Carcinoma, Ductal Stomach Neoplasms Carcinoma in Situ Neoplasms, Second Primary Triple Negative Breast Neoplasms Adenocarcinoma Inflammatory Breast Neoplasms Pancreatic Neoplasms Fibroadenoma Neovascularization, Pathologic Uterine Cervical Neoplasms Neoplastic Cells, Circulating Neoplasms, Basal Cell Carcinoma, Squamous Cell Colorectal Neoplasms

Chemicals and Drugs78

Neoplasm Proteins Cyclin D1 Cyclin A Cyclin E Cyclin B Cyclin B1 Cyclin D2 Cyclin A1 Cyclin D3 Receptors, Estrogen Cyclin A2 Cyclin D Receptor, erbB-2 Tamoxifen Receptors, Progesterone Tumor Markers, Biological Cyclins Antineoplastic Agents, Hormonal Cyclin G1 Cyclin G Antineoplastic Agents Cyclin C Cyclin-Dependent Kinases RNA, Messenger Estrogen Receptor alpha Estrogens Cyclin B2 Cyclin-Dependent Kinase 2 BRCA2 Protein BRCA1 Protein Estrogen Antagonists Cyclin T Aromatase Inhibitors RNA, Small Interfering Cyclin G2 Cell Cycle Proteins Cyclin-Dependent Kinase 4 DNA, Neoplasm Tumor Suppressor Proteins Cyclin H Tumor Suppressor Protein p53 Estradiol CDC2-CDC28 Kinases Fluorouracil Protein-Serine-Threonine Kinases Estrogen Receptor Modulators Cyclin-Dependent Kinase Inhibitor p27 Ki-67 Antigen Antibodies, Monoclonal, Humanized Transcription Factors Cyclophosphamide CDC2 Protein Kinase Nitriles Retinoblastoma Protein Selective Estrogen Receptor Modulators Epirubicin Antibodies, Monoclonal DNA-Binding Proteins Oncogene Proteins Proto-Oncogene Proteins Receptor, Epidermal Growth Factor RNA, Neoplasm Paclitaxel Cyclin-Dependent Kinase Inhibitor p21 Nuclear Proteins Anticarcinogenic Agents Antigens, Neoplasm Cancer Vaccines Triazoles Antigens, CD24 Proto-Oncogene Proteins c-akt Mucin-1 MicroRNAs Antibiotics, Antineoplastic DNA Primers Anthracyclines Cyclin I Enzyme Inhibitors

Analytical, Diagnostic and Therapeutic Techniques and Equipment71

Protein Interaction Mapping Mammography Prognosis Neoplasm Staging Early Detection of Cancer Mastectomy Risk Factors Chemotherapy, Adjuvant Immunohistochemistry Survival Analysis Antineoplastic Combined Chemotherapy Protocols Case-Control Studies Mammary Neoplasms, Experimental Gene Expression Profiling Reverse Transcriptase Polymerase Chain Reaction Disease-Free Survival Breast Self-Examination Risk Follow-Up Studies Survival Rate Blotting, Western Prospective Studies Risk Assessment Retrospective Studies Mastectomy, Segmental Odds Ratio Incidence Treatment Outcome Xenograft Model Antitumor Assays Transfection Multivariate Analysis Cohort Studies Oligonucleotide Array Sequence Analysis Registries Neoplasm Transplantation Transplantation, Heterologous Sensitivity and Specificity Ultrasonography, Mammary Tissue Array Analysis Predictive Value of Tests Kaplan-Meier Estimate Tumor Burden SEER Program Questionnaires Logistic Models Polymerase Chain Reaction Breast Implants Combined Modality Therapy Immunoenzyme Techniques Reproducibility of Results Neoplasm Grading Mass Screening Radiotherapy, Adjuvant Mammaplasty Confidence Intervals Models, Biological Clinical Trials as Topic Gene Knockdown Techniques Neoadjuvant Therapy Drug Screening Assays, Antitumor Genetic Testing Proportional Hazards Models In Situ Hybridization, Fluorescence Molecular Targeted Therapy Drug Administration Schedule Biopsy, Needle Sentinel Lymph Node Biopsy Radiotherapy Estrogen Replacement Therapy Flow Cytometry Biopsy

Psychiatry and Psychology2

Breast Feeding Breast Self-Examination

Phenomena and Processes49

Gene Expression Regulation, Neoplastic Cell Cycle Genes, BRCA1 Cell Proliferation Postmenopause Genetic Predisposition to Disease Drug Resistance, Neoplasm Breast Feeding Premenopause Risk Cell Division Menopause Genes, BRCA2 Apoptosis Signal Transduction Mutation Genes, erbB-2 Odds Ratio Time Factors Down-Regulation Phosphorylation G1 Phase Promoter Regions, Genetic Transfection Cell Movement Sensitivity and Specificity S Phase Genotype RNA Interference Cell Growth Processes Germ-Line Mutation Up-Regulation Gene Amplification Base Sequence Polymorphism, Genetic Gene Expression DNA Methylation Dose-Response Relationship, Drug Cell Survival Transcription, Genetic Gene Silencing Phenotype Mitosis Parity Genes, Tumor Suppressor Protein Binding Genes, bcl-1 Genes, Neoplasm Genes, p53

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena1

Quality of Life

Humanities1

Quality of Life

Information Science7

Survival Rate Incidence Registries Molecular Sequence Data SEER Program Questionnaires Base Sequence

Named Groups2

Survivors European Continental Ancestry Group

Health Care30

Risk Factors Survival Analysis Case-Control Studies Disease-Free Survival Risk Follow-Up Studies Survival Rate Prospective Studies Risk Assessment Retrospective Studies Age Factors Odds Ratio Incidence Treatment Outcome Multivariate Analysis Cohort Studies Registries Sensitivity and Specificity Predictive Value of Tests Kaplan-Meier Estimate SEER Program Questionnaires Logistic Models Reproducibility of Results Mass Screening Confidence Intervals Clinical Trials as Topic Parity Genetic Testing Proportional Hazards Models

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Information Science Named Groups Health Care Geographicals

Neoplasm Proteins Protein Interaction Mapping Cyclin D1 Breast Neoplasms Cyclin A Cyclin E Breast Neoplasms Cyclin B Cyclin B1 Carcinoma, Ductal, Breast Cyclin D2 Cyclin A1 Cyclin D3 Receptors, Estrogen Cell Line, Tumor Cyclin A2 Cyclin D Receptor, erbB-2 Breast Diseases Gene Expression Regulation, Neoplastic Tamoxifen Receptors, Progesterone Mammography Neoplasm Metastasis Neoplasm Invasiveness Prognosis Tumor Markers, Biological Cyclins Breast Neoplasms, Male Antineoplastic Agents, Hormonal Cyclin G1 Cyclin G Neoplasm Staging Antineoplastic Agents Early Detection of Cancer Mastectomy Cell Cycle Risk Factors Genes, BRCA1 Tumor Cells, Cultured Cell Proliferation Postmenopause Chemotherapy, Adjuvant Carcinoma, Lobular Mice, Nude Cyclin C Immunohistochemistry MCF-7 Cells Cyclin-Dependent Kinases Carcinoma, Intraductal, Noninfiltrating RNA, Messenger Genetic Predisposition to Disease Drug Resistance, Neoplasm Estrogen Receptor alpha Survival Analysis Breast Feeding Estrogens Carcinoma Antineoplastic Combined Chemotherapy Protocols Case-Control Studies Premenopause Mammary Neoplasms, Experimental Gene Expression Profiling Reverse Transcriptase Polymerase Chain Reaction Neoplasms, Hormone-Dependent Disease-Free Survival Breast Self-Examination Cyclin B2 Ovarian Neoplasms Lymphatic Metastasis Risk Follow-Up Studies Neoplasm Recurrence, Local Cyclin-Dependent Kinase 2 Cell Division Survival Rate Menopause BRCA2 Protein Blotting, Western BRCA1 Protein Lung Neoplasms Genes, BRCA2 Estrogen Antagonists Apoptosis Cyclin T Signal Transduction Prospective Studies Mutation Aromatase Inhibitors Fibrocystic Breast Disease Risk Assessment Disease Progression Retrospective Studies Genes, erbB-2 RNA, Small Interfering Age Factors Survivors Cyclin G2 Prostatic Neoplasms

No FAQ available that match "breast cancer protein called cyclin"